Brain Scientific, Creator of Next Gen Neurology Technologies, Announces Regulation A+ Offering
December 15, 2020 08:30 ET
|
Brain Scientific Inc.
NEW YORK, Dec. 15, 2020 (GLOBE NEWSWIRE) -- via NetworkWire -- Brain Scientific Inc. (OTCQB: BRSF), a neurology-focused medical device and software company, today announced it has launched a...
Karamedica Announces National Institute on Aging Grant to Continue Development of Microparticle Therapy for Cerebral Amyloid Angiopathy
December 15, 2020 07:55 ET
|
Karamedica, Inc.
RALEIGH, N.C., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Karamedica, Inc. recently received a $2.5 million Small Business Innovative Research (SBIR) Phase II grant from the National Institute on Aging to...
Global Cancer Stem Cells Market to Boost with CAGR of 11.8% and Cross a Margin of $1,898.3 Million During the Covid-19 Outbreak – Exclusive Report [150 Pages] by Research Dive
December 08, 2020 09:05 ET
|
Research Dive
New York, USA, Dec. 08, 2020 (GLOBE NEWSWIRE) -- The cancer stem cells market is anticipated to grow rapidly in the Covid-19 outbreak due to usage of cancer stem cells for treating cancer. According...
CNS Pharmaceuticals Featured in Syndicated Broadcast Covering Recent Announcements for Glioblastoma Multiforme (GBM) Therapy
November 24, 2020 08:00 ET
|
CNS Pharmaceuticals, Inc.
HOUSTON, Nov. 24, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – CNS Pharmaceuticals, Inc. (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary...
Grey Cloak Tech Inc. Releases Independent Report
October 20, 2020 08:30 ET
|
Grey Cloak Tech Inc.
LAS VEGAS, Oct. 20, 2020 (GLOBE NEWSWIRE) -- via NetworkWire -- Grey Cloak Tech Inc. (OTC: GRCK) (soon to be Healthy Extracts Inc. pending a corporate name change), a company engaged in proprietary...
CNS Pharmaceuticals and Image Analysis Group Partner to Further the Development of Berubicin
September 24, 2020 08:00 ET
|
CNS Pharmaceuticals, Inc.
HOUSTON, Sept. 24, 2020 (GLOBE NEWSWIRE) -- via NetworkWire -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel...
BrainBit Launches Demo App with Multiple Meditation Levels, Sleep Stages Analysis
June 15, 2020 07:00 ET
|
BrainBit Inc.
NEW YORK, June 15, 2020 (GLOBE NEWSWIRE) -- BrainBit, Inc, a Silicon Valley and NYC-based tech company specializing in smart wearable IoT devices for sport, wellness and entertainment applications,...
Denali Therapeutics Announces Publication of Two New Papers Describing Its Blood-Brain Barrier Delivery Technology in Science Translational Medicine
May 27, 2020 16:30 ET
|
Denali Therapeutics Inc.
Denali’s “Transport Vehicle” technology enables broad distribution and improved exposure levels of therapeutic proteins throughout the brainClinical proof of concept data with DNL310 (ETV:IDS), the...
Grey Cloak Tech Inc. Announces Acquisition of Ultimate Brain Nutrients
April 14, 2020 08:30 ET
|
Grey Cloak Tech Inc.
LAS VEGAS, April 14, 2020 (GLOBE NEWSWIRE) -- via NetworkWire - Grey Cloak Tech Inc. (OTC: GRCK) (the “Company”) today announces the completion of its acquisition of Ultimate Brain Nutrients, LLC...
Narbis Launches Smart Glasses Using Neurofeedback and NASA-Developed Algorithm to Encourage Practicing Focus and Concentration
October 29, 2019 08:00 ET
|
Narbis
AMBLER, Pa., Oct. 29, 2019 (GLOBE NEWSWIRE) -- Narbis, a technology company dedicated to developing wellness products that encourage practicing focus and concentration, today announced the online...